Polish Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

2 companies

Captor Therapeutics Spolka Akcyjna

Market Cap: zł164.6m

A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.

CTX

zł35.30

3.5%

-53.6%

Mabion

Market Cap: zł163.2m

A biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland.

MAB

zł10.10

-1.6%

-42.7%